Novel flexible heteroarotinoid, SL-1-39, inhibits HER2-positive breast cancer cell proliferation by promoting lysosomal degradation of HER2.

Hongye Zou, Mary B. Sevigny, Shengquan Liu, David T Madden, Maggie Louie

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalDefault journal
Volume443
DOIs
StatePublished - Feb 28 2019

Keywords

  • Breast Cancer
  • HER2
  • Heteroarotinoid
  • SHetA2

Disciplines

  • Life Sciences
  • Medicine and Health Sciences

Cite this